ArticleExperimental hematology2020

Panobinostat and venetoclax enhance the cytotoxicity of gemcitabine, busulfan, and melphalan in multiple myeloma cells.

Benigno C Valdez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.